Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other Working Capital Changes (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Other Working Capital Changes for 16 consecutive years, with $5000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes rose 101.26% year-over-year to $5000.0, compared with a TTM value of -$850000.0 through Sep 2025, up 78.79%, and an annual FY2024 reading of -$1.5 million, up 61.89% over the prior year.
  • Other Working Capital Changes was $5000.0 for Q3 2025 at Rockwell Medical, up from -$475000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $793000.0 in Q2 2023 and bottomed at -$2.9 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is -$582500.0, with a median of -$403500.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes crashed 273.85% in 2021, then skyrocketed 413.44% in 2023.
  • Year by year, Other Working Capital Changes stood at -$548000.0 in 2021, then plummeted by 134.49% to -$1.3 million in 2022, then plummeted by 128.4% to -$2.9 million in 2023, then soared by 87.05% to -$380000.0 in 2024, then surged by 101.32% to $5000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for RMTI at $5000.0 in Q3 2025, -$475000.0 in Q1 2025, and -$380000.0 in Q4 2024.